Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized phase II, placebo-controlled trial.

M.A. Carducci; R.J. Padley; J. Breul; N.J. Vogelzang; B.A. Zonnenberg; D.D. Daliani; C.C. Schulman; A.A. Nabulsi; R.A. Humerickhouse; R.A. Weinberg; J.L. Schmitt; J.B. Nelson

Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized phase II, placebo-controlled trial.

Translated title of the contribution: Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized phase II, placebo-controlled trial.

M.A. Carducci, R.J. Padley, J. Breul, N.J. Vogelzang, B.A. Zonnenberg, D.D. Daliani, C.C. Schulman, A.A. Nabulsi, R.A. Humerickhouse, R.A. Weinberg, J.L. Schmitt, J.B. Nelson

Division Imaging & Oncology

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized phase II, placebo-controlled trial.
Original language	Undefined/Unknown
Pages (from-to)	679-89
Number of pages	11
Journal	Journal of Clinical Oncology
Volume	15
Issue number	21
Publication status	Published - 2003

Cite this

Carducci, M. A., Padley, R. J., Breul, J., Vogelzang, N. J., Zonnenberg, B. A., Daliani, D. D., Schulman, C. C., Nabulsi, A. A., Humerickhouse, R. A., Weinberg, R. A., Schmitt, J. L., & Nelson, J. B. (2003). Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized phase II, placebo-controlled trial. Journal of Clinical Oncology, 15(21), 679-89.

@article{776d78851d0445d2b41dc42d91d3764c,

title = "Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized phase II, placebo-controlled trial.",

author = "M.A. Carducci and R.J. Padley and J. Breul and N.J. Vogelzang and B.A. Zonnenberg and D.D. Daliani and C.C. Schulman and A.A. Nabulsi and R.A. Humerickhouse and R.A. Weinberg and J.L. Schmitt and J.B. Nelson",

year = "2003",

language = "Undefined/Unknown",

volume = "15",

pages = "679--89",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "21",

}

Carducci, MA, Padley, RJ, Breul, J, Vogelzang, NJ, Zonnenberg, BA, Daliani, DD, Schulman, CC, Nabulsi, AA, Humerickhouse, RA, Weinberg, RA, Schmitt, JL & Nelson, JB 2003, 'Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized phase II, placebo-controlled trial.', Journal of Clinical Oncology, vol. 15, no. 21, pp. 679-89.

Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized phase II, placebo-controlled trial. / Carducci, M.A.; Padley, R.J.; Breul, J. et al.
In: Journal of Clinical Oncology, Vol. 15, No. 21, 2003, p. 679-89.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized phase II, placebo-controlled trial.

AU - Carducci, M.A.

AU - Padley, R.J.

AU - Breul, J.

AU - Vogelzang, N.J.

AU - Zonnenberg, B.A.

AU - Daliani, D.D.

AU - Schulman, C.C.

AU - Nabulsi, A.A.

AU - Humerickhouse, R.A.

AU - Weinberg, R.A.

AU - Schmitt, J.L.

AU - Nelson, J.B.

PY - 2003

Y1 - 2003

M3 - Article

SN - 0732-183X

VL - 15

SP - 679

EP - 689

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 21

ER -